GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bide Pharmatech Co Ltd (SHSE:688073) » Definitions » Effective Interest Rate on Debt %

Bide Pharmatech Co (SHSE:688073) Effective Interest Rate on Debt % : 4.69% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Bide Pharmatech Co Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Bide Pharmatech Co's annualized positive value of Interest Expense for the quarter that ended in Mar. 2024 was ¥3 Mil. Bide Pharmatech Co's average total debt for the quarter that ended in Mar. 2024 was ¥73 Mil. Therefore, Bide Pharmatech Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 was 4.69%.


Bide Pharmatech Co Effective Interest Rate on Debt % Historical Data

The historical data trend for Bide Pharmatech Co's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bide Pharmatech Co Effective Interest Rate on Debt % Chart

Bide Pharmatech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial 9.93 5.64 2.68 6.31 5.16

Bide Pharmatech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.38 5.01 4.10 6.55 4.69

Competitive Comparison of Bide Pharmatech Co's Effective Interest Rate on Debt %

For the Drug Manufacturers - Specialty & Generic subindustry, Bide Pharmatech Co's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bide Pharmatech Co's Effective Interest Rate on Debt % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bide Pharmatech Co's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Bide Pharmatech Co's Effective Interest Rate on Debt % falls into.



Bide Pharmatech Co Effective Interest Rate on Debt % Calculation

Bide Pharmatech Co's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2022 )+Total Debt  (A: Dec. 2023 ))/ count )
=-1  *  -2.53/( (40.818+57.297)/ 2 )
=-1  *  -2.53/49.0575
=5.16 %

where

Total Debt  (A: Dec. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=31.209 + 9.609
=40.818

Total Debt  (A: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=41.186 + 16.111
=57.297

Bide Pharmatech Co's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2023 )+Total Debt  (Q: Mar. 2024 ))/ count )
=-1  *  -3.428/( (57.297+88.84)/ 2 )
=-1  *  -3.428/73.0685
=4.69 %

where

Total Debt  (Q: Dec. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=41.186 + 16.111
=57.297

Total Debt  (Q: Mar. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=32.041 + 56.799
=88.84

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Bide Pharmatech Co  (SHSE:688073) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Bide Pharmatech Co Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Bide Pharmatech Co's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Bide Pharmatech Co (SHSE:688073) Business Description

Traded in Other Exchanges
N/A
Address
No. 128, Xiangyin Road, Room 101, Block A, Building 11, Yangpu District, Shanghai, CHN, 200433
Bide Pharmatech Co Ltd is engaged in the research and development, design, production and sales of drug molecular building blocks.
Executives
Dai Lan Director

Bide Pharmatech Co (SHSE:688073) Headlines

No Headlines